Referências:
[i] Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr. 1994;14:269-96.
[ii] Zierenberg, O. and Grundy, S.M., J. Lipid. Res., 23:1136 (1982).
[iii] Dargel R. et al., Z. Gastroenteral. 29 (Suppl. 2):18 (1991).
[iv] Indovina, J. et al., Epatologica, 27:261 (1981).
[v] Navder K. P. and Lieber C. S., Biochem. Biophys. Res. Commun. 291:1109 (2002).
[vi] Chanussot, F. and Benaoel, L., Life Sciences 73:381 (2003).
[vii] Saratikov A.S. and Vengerovskii A.I., Biull. Eksp. Biol. Med. 127:392 (1999).
[viii] C. S. Lieber, S. J. Robins, M. A. Leo Hepatic Phosphatidylethanolamine Methyltransferase Activity Is Decreased by Ethanol and Increased by Phosphatidylcholine , Alcoholism: Clinical and Experimental Research
Volume 18, Issue 3, pages 592–595, June 1994
[ix] Knuchel F. Double blind study in patients with alcohol-toxic fatty liver. Med Welt 1979;30:411-416.
[x] Schuller-Perez A, San Martin FG. Controlled study using multiply-unsatured phosphatidylcholine in comparison with placebo in the case of alcoholic liver steatosis. Med Welt 1985; 72:517-521.
[xi] Charles S. Lieber, Sander J. Robins, et al Phosphatidylcholine Protects Against Fibrosis and Cirrhosis in the Baboon. Gastroenterology, 1994;106:152-159.[xii] Li-Jun Mi, Ki M. Mak, Charles S. Lieber* Attenuation of Alcohol-Induced Apoptosis of Hepatocytes in Rat Livers by Polyenylphosphatidylcholine (PPC) Alcoholism: Clinical and Experimental Research Volume 24, Issue 2, pages 207–212, February 2000
[xiii] Buchman AL, Ament ME, Sohel M, et al. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. JPEN J Parenter Enteral Nutr. Sep-Oct 2001;25(5):260-268.
[xiv] MARPAUNG B, TARIGAN P, ZEIN LH, ET AL. Tuberkulostatische Kombinationstherapie aus INH, RMP und EMB. Therapiewoche 1988;38:734-740.
[xv] Peter J. Jenkins*, B. P. Portmann, A. L. W. F. Eddleston, Roger Williams; Use of polyunsaturated phosphatidyl choline in HBsAg negative chronic active hepatitis: results of prospective double-blind controlled trial; Liver Volume 2, Issue 2, pages 77–81, June 1982
[xvi] Visco G. Polyunsaturated phosphatidylcholine in association with vitamin B complex in the treatment of acute viral hepatitis B. Results of a randomized double-blind clinical study. Clin Ter. 1985 Aug 15;114(3):183-8.
[xvii] Ilic V, Begic-Janew A. Therapy for HBsAg-positive chronically active hepatitis.Med Welt 1991; 523-525.
[xviii] Niederau C, Strohmeyer G, Heintges T, Peter K, Göpfert E.Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group. Hepatogastroenterology. 1998 May-Jun;45(21):797-804.
“As informações fornecidas neste site destinam-se ao conhecimento geral e não devem ser um substituto para o profissional médico ou tratamento de condições médicas específicas. Procure sempre o aconselhamento do seu médico ou outro prestador de cuidados de saúde qualificado com qualquer dúvida que possa ter a respeito de sua condição médica. As informações contidas aqui não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. Nunca desconsidere o conselho médico ou demore na procura por causa de algo que tenha lido em nosso site e mídias sociais da Essential.”